Ordering Recommendation

Not recommended in the initial evaluation of autoimmune thyroid disease. Most often used to evaluate potentially unreliable thyroglobulin measurements in thyroid carcinomas.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Serum separator tube.

Specimen Preparation

Transfer 0.5 mL serum to an ARUP Standard Transport Tube. (Min: 0.3 mL) Also acceptable: Heparinized plasma.

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

EDTA plasma. Grossly hemolyzed or lipemic specimens.

Remarks
Stability

After separation from cells: Ambient: 8 hours; Refrigerated: 1 week; Frozen: 6 months

Methodology

Quantitative Chemiluminescent Immunoassay

Performed

Sun-Sat

Reported

Within 24 hours

Reference Interval

Effective May 7, 2012

0.0-4.0 IU/mL

Interpretive Data

A value of 4.0 IU/mL or less indicates a negative result for thyroglobulin antibodies.

The Thyroglobulin Antibody assay is being performed using the Beckman Coulter Access Dxl method.

Compliance Category

FDA

Note

Hotline History

N/A

CPT Codes

86800

Components

Component Test Code* Component Chart Name LOINC
0050105 Thyroglobulin Antibody 8098-6
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Anti-Thyroglobulin Antibody
  • Thyroglobulin Antibody
Thyroglobulin Antibody